Effect of the Orally Administered PKC b Inhibitor, Ruboxistaurin, on Sustained Moderate Visual Loss in the PKC-DRS2 Study

Publication Type
Conference Paper
Year of Publication
2006
Authors
Aiello, LP; Vignati, L; Sheetz, MJ; Zhi, X; Girach, A; Davis, MD; Milton, R; The PKC-DRS2 Study Group
Secondary
29th Annual Meeting of the Macula Society
Date Published
02/2006
Location
San Diego, CA